CBOE · ISDB
Invesco Short Duration Bond ETF
$24.99+$0.03 (+0.12%)
Invesco Short Duration Bond ETF’s quoted price sits in the upper half of its reported 52-week range, 1.25% below the high.
Loading market information…
CBOE · ARKZ · USD
Stock price, dividends
Quote as of Sep 25, 2025, 07:31 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
EA Series Trust - ARK 21Shares Active Ethereum Futures Strategy ETF’s quoted price sits in the upper half of its reported 52-week range, 12.17% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
EA Series Trust - ARK 21Shares Active Ethereum Futures Strategy ETF’s forward annual dividend is $178.08 per share, paid quarterly. The forward yield is 400.52% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The ARKZ fund primarily holds standardized, cash-settled Ether futures contracts which are traded on the Chicago Mercantile Exchange (CME). A significant portion, targeted at over 25% of its total assets, is allocated to these futures through a subsidiary established in the Cayman Islands. The fund actively manages its futures positions using a "rolling strategy". This approach seeks to maximize "roll yield" by selecting contracts that offer the most advantageous combination of factors, such as transaction costs, market liquidity, and other pertinent considerations. These chosen contracts typically have monthly or quarterly expiration periods. This often involves investing in front-month (nearest-term) Ether futures and subsequently transitioning these positions to the next available contract when it is deemed most beneficial for generating optimal roll yield. Remaining capital not deployed in futures is invested in a diversified portfolio of short-term cash instruments. These holdings, which include U.S. Treasury securities and money market instruments, serve to maintain liquidity and provide collateral for the Ether Futures investments. Furthermore, the fund has the flexibility to employ leverage through the use of reverse repurchase agreements.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Nov 1, 2026, 04:22 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$24.99+$0.03 (+0.12%)
Invesco Short Duration Bond ETF’s quoted price sits in the upper half of its reported 52-week range, 1.25% below the high.
$22.28+$0.03 (+0.14%)
KraneShares MSCI All China Index ETF’s quoted price sits in the lower half of its reported 52-week range, 20.42% below the high.
$24.59+$0.00 (0.0%)
Hartford Schroders ESG US Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 0.6% below the high.
$30.49-$0.48 (-1.55%)
WisdomTree Growth Leaders Fund’s quoted price sits in the upper half of its reported 52-week range, 12.87% below the high.
$68.45-$0.74 (-1.07%)
Direxion S&P 500 High minus Low Quality ETF’s quoted price sits in the upper half of its reported 52-week range, 3.92% below the high.
$24.60-$0.06 (-0.22%)
iPath Series B Bloomberg Agriculture Subindex Total Return ETN’s quoted price sits in the lower half of its reported 52-week range, 6.85% below the high.
$27.33+$0.04 (+0.13%)
iMGP DBi Hedge Strategy ETF’s quoted price sits in the upper half of its reported 52-week range, 1.99% below the high.
$19.16-$0.06 (-0.29%)
ETFMG Treatments, Testing and Advancements ETF’s quoted price sits in the upper half of its reported 52-week range, 5.16% below the high.
